Mycamine Injection, Powder, Lyophilized, For Solution
Product Images NDC 0469-3250

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mycamine (NDC 0469-3250). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Astellas Pharma Us, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Micafungin Sodium Structural Formula (Image 01)

Chemical structure diagram showing the molecular formula of the active ingredient in Mycamine 10 mg/mL by Astellas Pharma US, Inc.*

FDA Label Image

Carton 50 mg/vial (Image 02)

Mycamine 50 mg/vial (micafungin) for injection packaging label. The label specifies it is for intravenous infusion only, single-dose vial, preservative-free, and manufactured by Astellas Pharma US, Inc. The label includes storage instructions, ingredient details, and barcode images.*

FDA Label Image

Carton 100 mg/vial (Image 03)

Packaging label for Mycamine 100 mg/vial (micafungin) for injection, a sterile, nonpyrogenic intravenous infusion single-dose vial. The label includes handling instructions, storage conditions, preservative warning, and manufacturer information: Astellas Pharma US, Inc. The label is primarily white with red and black text and features multiple barcodes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.